Literature DB >> 27475660

Cardiovascular Disease Consequences of CKD.

Alan S Go1.   

Abstract

Chronic kidney disease, defined as reduced glomerular filtration rate (estimated using serum creatinine- and/or serum cystatin C-based equations) or excess urinary protein excretion, affects approximately 13% of adult Americans and is linked to a variety of clinical complications. Although persons with end-stage renal disease requiring chronic dialysis therapy experience a substantially high cardiovascular burden, whether mild-to-moderate chronic kidney disease is an independent risk factor for fatal and nonfatal cardiovascular events has been more controversial. This review evaluates the current evidence about the clinical and subclinical cardiovascular consequences associated with chronic kidney disease of varying levels of severity. In addition, it discusses the predictors of adverse cardiovascular outcomes while also focusing on recent insights into the relationships between chronic kidney disease and cardiovascular disease from the Chronic Renal Insufficiency Cohort study, a large current prospective cohort study of adults from across the spectrum of chronic kidney disease.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Chronic kidney disease; cardiovascular disease; heart failure; myocardial infarction; risk factor

Mesh:

Year:  2016        PMID: 27475660     DOI: 10.1016/j.semnephrol.2016.05.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  12 in total

1.  Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.

Authors:  Farsad Afshinnia; Lixia Zeng; Jaeman Byun; Crystal A Gadegbeku; Maria Chiara Magnone; Carl Whatling; Barbara Valastro; Matthias Kretzler; Subramaniam Pennathur
Journal:  Am J Nephrol       Date:  2017-07-01       Impact factor: 3.754

2.  αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.

Authors:  Paulo Giovani de Albuquerque Suassuna; Paula Marocolo Cherem; Bárbara Bruna de Castro; Edgar Maquigussa; Marco Antonio Cenedeze; Júlio Cesar Moraes Lovisi; Melani Ribeiro Custódio; Helady Sanders-Pinheiro; Rogério Baumgratz de Paula
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-17

3.  IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.

Authors:  Ozkan Gungor; Hilmi Umut Unal; Aydin Guclu; Mustafa Gezer; Tayfun Eyileten; Fatma Betül Guzel; Orcun Altunoren; Ertugrul Erken; Yusuf Oguz; Ismail Kocyigit; Mahmut Ilker Yilmaz
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

4.  Progression of Aortic Arch Calcification Is Associated with Overall and Cardiovascular Mortality in Hemodialysis.

Authors:  Wei-Shiuan Chung; Ming-Chen Paul Shih; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen; Yi-Wen Chiu; Jer-Ming Chang; Hung-Chun Chen
Journal:  Dis Markers       Date:  2020-06-20       Impact factor: 3.434

5.  Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.

Authors:  Xujiao Chen; Shouhong Gao; Mengna Ruan; Sixiu Chen; Jing Xu; Xiaohong Xing; Xiaohong Pan; Changlin Mei; Zhiguo Mao
Journal:  Biosci Rep       Date:  2018-09-13       Impact factor: 3.840

6.  Optimal cut-off threshold in pulse pressure predicting cardiovascular death among newly diagnosed end-stage renal disease patients: A prospective cohort study.

Authors:  Zheng Wang; Dahai Yu; Yamei Cai; Bin Zhao; Xiaoxue Zhang; Zhanzheng Zhao
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.

Authors:  Noboru Ichihara; Masatoshi Miyamura; Daichi Maeda; Tomohiro Fujisaka; Shu-Ichi Fujita; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Arrhythm       Date:  2017-05-30

Review 8.  The Vitamin K Metabolome in Chronic Kidney Disease.

Authors:  Mandy E Turner; Michael A Adams; Rachel M Holden
Journal:  Nutrients       Date:  2018-08-12       Impact factor: 5.717

Review 9.  Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.

Authors:  Paulo G de Albuquerque Suassuna; Helady Sanders-Pinheiro; Rogério B de Paula
Journal:  Front Med (Lausanne)       Date:  2018-07-24

10.  Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry.

Authors:  Emmanuelle Vidal-Petiot; Nicola Greenlaw; Paul R Kalra; Xavier Garcia-Moll; Jean-Claude Tardif; Ian Ford; Jose Zamorano; Roberto Ferrari; Michal Tendera; Kim M Fox; Philippe Gabriel Steg
Journal:  J Clin Med       Date:  2019-12-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.